Page last updated: 2024-09-04

resiquimod and rimantadine

resiquimod has been researched along with rimantadine in 2 studies

Compound Research Comparison

Studies
(resiquimod)
Trials
(resiquimod)
Recent Studies (post-2010)
(resiquimod)
Studies
(rimantadine)
Trials
(rimantadine)
Recent Studies (post-2010) (rimantadine)
4651431865147138

Protein Interaction Comparison

ProteinTaxonomyresiquimod (IC50)rimantadine (IC50)
Solute carrier family 22 member 2Homo sapiens (human)4.4
Multidrug and toxin extrusion protein 1Homo sapiens (human)7.3

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Bhardwaj, N; Fernandez, MV; Gopal, R; Greenbaum, BD; Krammer, F; Miller, E1

Other Studies

2 other study(ies) available for resiquimod and rimantadine

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Ion efflux and influenza infection trigger NLRP3 inflammasome signaling in human dendritic cells.
    Journal of leukocyte biology, 2016, Volume: 99, Issue:5

    Topics: Amantadine; Apoptosis; Caspase 1; Dendritic Cells; Humans; Imidazoles; Inflammasomes; Influenza A virus; Interferons; Interleukin-1; Ion Transport; Ions; Monocytes; NLR Family, Pyrin Domain-Containing 3 Protein; Rimantadine; Signal Transduction; Toll-Like Receptors; Up-Regulation

2016